Literature DB >> 16301805

Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1.

Anowara Begum1, M Mushfequr Rahman, Wakano Ogawa, Tohru Mizushima, Teruo Kuroda, Tomofusa Tsuchiya.   

Abstract

There are six putative genes for multidrug and toxic compound extrusion (MATE) family multidrug efflux pumps in the chromosome of Vibrio cholerae. We have so far analyzed two MATE family pumps in V. cholerae non-O1 NCTC4716. Here we cloned four remaining genes for putative MATE family efflux pumps by the PCR method from this microorganism and designated them as vcmB, vcmD, vcmH and vcmN. Each one of the four genes was introduced and expressed in the drug hypersusceptible host Escherichia coli KAM32 cells. We observed elevated MICs of multiple antimicrobial agents, such as fluoroquinolones, aminoglycosides, ethidium bromide and Hoechst 33342 in the transformants. Energydependent efflux of substrate was observed with the transformed cells. We found that efflux activities of VcmB, VcmD and VcmH were Na+-dependent, but that of VcmN was Na+-independent. Thus, all six of the MATE family multidrug efflux pumps of V. cholerae non-O1 have been characterized. We also found that all six genes were expressed in cells of V. cholerae non-O1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301805     DOI: 10.1111/j.1348-0421.2005.tb03690.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  18 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 2.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

Review 3.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.

Authors:  Elisabeth Aslangul; Laurent Massias; Alain Meulemans; Françoise Chau; Antoine Andremont; Patrice Courvalin; Bruno Fantin; Raymond Ruimy
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

5.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

6.  Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance.

Authors:  Anil Kumar Singh; Rajen Haldar; Debabrata Mandal; Manikuntala Kundu
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

7.  Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395.

Authors:  Kenneth P Smith; Sanath Kumar; Manuel F Varela
Journal:  Arch Microbiol       Date:  2009-10-30       Impact factor: 2.552

8.  Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.

Authors:  Feng Long; Corinne Rouquette-Loughlin; William M Shafer; Edward W Yu
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

Review 9.  Biochemistry of bacterial multidrug efflux pumps.

Authors:  Sanath Kumar; Manuel F Varela
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

Review 10.  Antimicrobials & cholera: are we stranded?

Authors:  Amit Ghosh; T Ramamurthy
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.